跳至主要内容
临床试验/NCT04129242
NCT04129242已完成1 期

Optimization of Closed-loop Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) as a Neurorehabilitation Tool

Medical University of South Carolina1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2020年2月19日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
20
试验地点
1
主要终点
Change in Fugl-Meyer Assessment of the Upper Extremity

研究概览

简要总结

This study explores the use of a new form of neuromodulation known as transcutaneous auricular vagus nerve stimulation (taVNS) which stimulates the ear. This stimulation will be delivered concurrently with upper limb motor rehabilitation training (3 days/week for 4 weeks) in chronic stroke patients. Patients will undergo a series of baseline assessments (including a brain scan), a 4-week course of motor rehabilitation, and post-assessments (including a second brain scan)

详细描述

This study aims to refine and develop closed loop taVNS, establish activity with key biomarkers, and show initial feasibility in a small clinical trial. For paired taVNS to succeed as a clinical treatment, it is critical to develop and refine a closed-loop taVNS platform that delivers stimulation concurrently during specific movements of the motor rehabilitation training.

Aim 1 develops this novel motion-gated closed-loop system that delivers taVNS in synchrony with specific upper limb motor activation (n=5) Aim 2 will combine the development of the closed-loop system with the investigator's mechanistic understanding to explore an open-label pilot trial (n=20) using closed-loop taVNS paired with task-specific training to determine the feasibility, safety, and potential effect size of this novel combination therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •18-80 years old
  • •Ischemic or hemorrhagic stroke that occurred at least 6 months prior
  • •Completed conventional rehabilitation therapy at least one month prior
  • •Unilateral limb weakness with Fugl Meyer-Upper Extremity Scale score less than or equal to 58 (out of 66)

排除标准

  • •Primary intracerebral hematoma, or subarachnoid hemorrhage
  • •Bilateral upper extremity weakness
  • •Other concomitant neurological disorders affecting upper extremity motor function
  • •Documented history of dementia before or after stroke
  • •Documented history of uncontrolled depression or psychiatric disorder either before or after stroke which could affect their ability to participate in the experiment
  • •Uncontrolled hypertension despite treatment, specifically SBP (Systolic Blood Pressure) / DBP (Diastolic Blood Pressure) >=180/100mmHg at baseline
  • •Contraindicated for MRI scanning.

研究组 & 干预措施

"paired" taVNS + Task Specific Training

Active Comparator

干预措施: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) + Task Specifc Training (Device)

"unpaired" taVNS + Task Specific Training

Active Comparator

干预措施: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) + Task Specifc Training (Device)

结局指标

主要结局

Change in Fugl-Meyer Assessment of the Upper Extremity

时间窗: Mean change in FMA-UE score after 4 weeks of rehab, compared to baseline

The Fugl-Meyer Assessment of the Upper Extremity (FMA-UE) is a stroke rehabilitation assessment of arm/hand movement impairment. It is scored by assigning 30 items assessing voluntary arm/hand movements and 3 items assessing reflexes an ordinal rating (0=unable, 1=partial, 2=near normal), then summing the ratings to obtain a general statement of ability. Possible aggregate scores range from 0/66 to 66/66 points. Higher scores indicate greater levels of arm movement ability.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bashar Badran

Assistant Professor

Medical University of South Carolina

研究点 (1)

Loading locations...

相似试验